The high expression of RFX6 in HCC and its negative role in the prognosis and CD8+ T-cell infiltration support the notion that RFX6 helps promote liver hepatocellular tumorigenesis and may be related to antitumor immunity mediated by CD8+ T cells. The gene discussed is RFX6; the disease is hepatocellular carcinoma.